An inhibitor of PDE3
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Pimobendan

Item No. 26082

Technical Information
Formal Name
4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone
CAS Number
74150-27-9
Synonyms
  • UD-CG 115
Molecular Formula
C19H18N4O2
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 1 mg/mlDMSO: 5 mg/mlDMSO:PBS (pH 7.2) (1:7): 0.125 mg/ml
λmax
268, 329 nm
SMILES
CC(C(C1=CC=C(N=C(C2=CC=C(OC)C=C2)N3)C3=C1)=NN4)CC4=O
InChi Code
InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)
InChi Key
GLBJJMFZWDBELO-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Pimobendan is an inhibitor of phosphodiesterase 3 (PDE3; IC50 = 0.32 μM for guinea pig cardiac enzyme) that is selective for PDE3 over PDE1, PDE2, and PDE4 (IC50s = >30 μM).1 It is also a calcium sensitizer, decreasing the concentration of calcium required for half-maximal contractile force in isolated, skinned porcine ventricular fibers. Pimobendan increases the force of contraction in electrically-stimulated isolated guinea pig papillary muscles with an EC50 value of 6 μM, indicating positive inotropic effects.2 It increases survival time in dogs with congestive heart failure due to myxomatous mitral valve disease when administered in combination with angiotensin-converting enzyme inhibitors and furosemide (Item No. 17273).3 Formulations containing pimobendan have been used in the treatment of heart failure in dogs.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Beier, N., Harting, J., Jonas, R., et alThe novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer". J. Cardiovasc. Pharmacol. 18(1), 17-27 (1991).

    2. Brunkhorst, D., v der Leyen, H., Meyer, W., et alRelation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. Naunyn Schmiedebergs Arch. Pharmacol. 339(5), 575-583 (1989).

    3. Mizuno, M., Yamano, S., Chimura, S., et alEfficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. J. Vet. Med. Sci. 79(1), 29-34 (2017).